Real-world (RW) risk of recurrence among patients (pts) diagnosed with stage II-III HR+/HER2-early breast cancer (EBC) treated with endocrine therapy (ET) in the US Meeting Abstract


Authors: Razavi, P.; Ahmed, M.; Roush, A.; Parikh, R.; Hitchens, A.; Shen, S.; Safonov, A.; Jhaveri, K. L.; Robson, M. E.; Peacock, N. W.; Ma, Y.; Santarsiero, E. C.; Ganapathy, V.; Shah, R. M.; Amefule, A. Q.; Lteif, A.; Blakely, L. J.
Abstract Title: Real-world (RW) risk of recurrence among patients (pts) diagnosed with stage II-III HR+/HER2-early breast cancer (EBC) treated with endocrine therapy (ET) in the US
Meeting Title: 2024 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 16 Suppl.
Meeting Dates: 2024 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-06-01
Language: English
ACCESSION: WOS:001275557403004
PROVIDER: wos
DOI: 10.1200/JCO.2024.42.16_suppl.e12533
Notes: Meeting Abstract: e12533 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark E Robson
    676 Robson
  2. Komal Lachhman Jhaveri
    201 Jhaveri
  3. Pedram Razavi
    172 Razavi
  4. Sherry Shen
    22 Shen
  5. Anton Safonov
    30 Safonov
  6. Mehnaj Sarah Ahmed
    7 Ahmed